Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 1988The Journal of Urology

Role of Fibronectin in Intravesical BCG Therapy for Superficial Bladder Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

TRTimothy L. RatliffPurdue University NorthwestLKLouis R. KavoussiTulane UniversityWCWilliam J. CatàlonaBoston University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ratliff et al. (1988) studied this question.

synapsesocial.com/papers/6a6fcd22a528af2d65c32cachttps://doi.org/10.1016/s0022-5347(17)42445-1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of intravesical bacillus calmette-guerin (BCG) on carcinomain situ of the bladder1983 · 121 citations
  2. 2The Mechanism of Human Bladder Tumor Implantation in an in Vitro Model1986 · 103 citations
  3. 3Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder Carcinoma1982 · 317 citations
  4. 4Prognostic Value of Purified Protein Derivative Skin Test and Granuloma Formation in Patients Treated with Intravesical Bacillus Calmette-Guerin1986 · 107 citations
  5. 5Studies on the fibronectin receptors of human peripheral blood leukocytes. Morphologic and functional characterization.1984 · 109 citations